Scinai Immunotherapeutics Ltd - American Depositary Shares - estatísticas financeiras trimestrais (NASDAQ:SCNI) | MetaTrader

Abrir gráfico completo

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Notícias

Scinai conclui reorganização corporativa e separa unidade CDMO

Scinai recebe ampliação de subsídio para sistema robótico de fabricação

Scinai receives expanded grant for robotic manufacturing system

Scinai reporta crescimento de receita com expansão do negócio CDMO

Scinai reports revenue growth as CDMO business expands

Scinai Immunotherapeutics agenda assembleia anual para 22 de dezembro

Scinai Immunotherapeutics schedules annual meeting for December 22

Scinai recebe subsídio de US$ 246.000 para expandir fabricação biotecnológica

Scinai receives $246,000 grant to expand biotech manufacturing

Scinai Immunotherapeutics stock soars on promising skin disease drug data

Scinai’s PC111 antibody shows promise for pemphigus treatment

Scinai Reports Q1 2025 Financial Results Highlighting Strong CDMO Revenue Momentum and Reduced Cash Burn